Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
Hallmarks of glioblastoma: a systematic review
Dorte Schou Nørøxe, Hans Skovgaard Poulsen,
Ulrik Lassen
Institut for Klinisk Medicin
52
Citationer (Scopus)
60
Downloads (Pure)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Hallmarks of glioblastoma: a systematic review'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Medicine and Dentistry
Glioblastoma
100%
Systematic Review
100%
Cell Energy
50%
Biological Marker
25%
Intracranial Tumor
25%
DNA Methyltransferase
25%
Angiogenesis
25%
Immunity
25%
Next Generation Sequencing
25%
Personalized Medicine
25%
Overall Survival
25%
Molecular Diagnostics
25%
Progression Free Survival
25%
Adjuvant Chemotherapy
25%
Predictive Marker
25%
Chemoradiotherapy
25%
Malignant Neoplasm
25%
Diagnosis
25%
Division
25%
Temozolomide
25%
Keyphrases
Glioblastoma
100%
Molecular Diagnostics
25%
Clinical Impact
25%
Brain Tumor
25%
Genetic Aberrations
25%
Next-generation Sequencing
25%
Treatment Decisions
25%
Precision Medicine
25%
Daily Life
25%
Diagnostic Criteria
25%
Clinical Outcomes
25%
Adjuvant Chemotherapy
25%
Progression-free Survival
25%
Prognostic Biomarker
25%
Temozolomide
25%
Overall Survival
25%
WHO Classification
25%
Angiogenesis
25%
Response to Treatment
25%
Predictive Marker
25%
Cancer Hallmarks
25%
O6-methylguanine-DNA Methyltransferase
25%
Biochemistry, Genetics and Molecular Biology
Cell Energy
100%
Reprogramming
100%
Next Generation Sequencing
50%
Genomics
50%
Overall Survival
50%
Progression Free Survival
50%
Angiogenesis
50%
Immunity
50%
Neuroscience
Cell Energy
100%
Reprogramming
100%
DNA Methyltransferase
50%
Temozolomide
50%
Angiogenesis
50%
Intracranial Tumor
50%
6-O-Methylguanine
50%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Chemotherapy
50%
Progression Free Survival
25%
Intracranial Tumor
25%
Malignant Neoplasm
25%
Temozolomide
25%
Overall Survival
25%
DNA Methyltransferase
25%
Biological Marker
25%
6 O Methylguanine
25%